Actuate Therapeutics, Inc.
ACTU
$2.15
-$0.12-5.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.54% | 15.22% | 14.35% | 8.87% | -10.27% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.71% | 71.96% | 128.94% | 321.28% | 693.89% |
| Change in Net Operating Assets | -376.85% | -172.29% | -142.20% | -113.57% | -57.24% |
| Cash from Operations | 12.07% | 10.36% | -19.10% | 1.40% | -1.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -96.36% | -73.33% | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 0.29% | 0.29% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.32% | 78.98% | -1,142.41% | -1,245.87% | -- |
| Cash from Financing | -13.81% | -14.44% | 442.98% | 282.11% | 565.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.50% | -32.68% | 144.64% | 111.76% | 132.49% |